MAP3K12 and breast neoplasm: In this way, evaluation of genes with somatic point mutations in breast tumors as compiled in the COSMIC database (release v36) [81] placed MAP3K12 at the top of the combined rank (Additional file 7), which reinforces the putative involvement of the MAPK signaling pathway and supports MAP3K12 as a likely candidate.